(E)-2-hydroxy-N-(2-(2-hydroxybenzylideneamino)ethyl)benzamide | 1202748-52-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-2-hydroxy-N-(2-(2-hydroxybenzylideneamino)ethyl)benzamide
• CAS: 1202748-52-4
• 化学式: C₁₆H₁₆N₂O₃
• 分子量: 284.315
• InChiKey: JLCDKYMQBWXXOH-GZTJUZNOSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.95
• 重原子数：
  21.0
• 可旋转键数：
  5.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  81.92
• 氢给体数：
  3.0
• 氢受体数：
  4.0

反应信息

• 作为产物：
  描述：

  N-(2-氨基乙基)-2-羟基苯甲酰胺 、 水杨醛 以 甲醇 为溶剂， 反应 3.0h， 以88%的产率得到(E)-2-hydroxy-N-(2-(2-hydroxybenzylideneamino)ethyl)benzamide
  参考文献：
  名称：

  Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics

  摘要：

  A series of peptide and Schiff bases (PSB) were synthesized by reacting salicylic acid, primary diamines with salicylaldehyde or its derivatives, and 40 of which were newly reported. The inhibitory activities against Escherichia coli beta-ketoacyl-acyl carrier protein synthase III (ecKAS III) were investigated in vitro and molecular docking simulation also surveyed. Top 10 PSB compounds which posses both good inhibitory activity and well binding affinities were picked out, and their antibacterial activities against Gram-negative and Gram-positive bacterial strains were tested, expecting to exploit potent antibacterial agent with broad-spectrum antibiotics activity. The results demonstrate compound N-(3-(5-bromo-2-hydroxybenzylideneamino)propyl)-2-hydroxybenzamide (2d) can be as a potential antibiotics agent, displaying minimal inhibitory concentration values in the range of 0.39-3.13 mu g/mL against various bacteria. Crown Copyright (c) 2009 Published by Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2009.10.037

文献信息

• Metall-Komplexe als Bleichaktivatoren
  申请人：Clariant GmbH

  公开号：EP0889050A2

  公开（公告）日：1999-01-07

  Metall-Komplexe der allgemeinen Formel 1         [LnMmXp]zYq     (1) wobei Mfür Mangan in der Oxidationsstufe II, III, IV, V und/oder VI oder Kobalt in der Oxidationsstufe II und/oder III oder Eisen in der Oxidationsstufe II und/oder III, Xeine Koordinations- oder Brückengruppe, Yein Gegenion in der entsprechenden stöchiometrischen Menge zum Ausgleich einer vorhandenen Ladung z, wobei zals Ladung des Metall-Komplexes positiv, null oder negativ sein kann, n und munabhängig voneinander ganze Zahlen von 1 bis 4, peine ganze Zahl von 0 bis 15, qz/Ladung von Y Leinen Liganden der Formel (2), (3) oder (4) bedeuten und A und R1 bis R8 die in der Beschreibung genannten Bedeutungen haben.

  通式 1 的金属配合物 [LnMmXp]zYq (1) 其中 M 代表氧化态为 II、III、IV、V 和/或 VI 的锰，或氧化态为 II 和/或 III 的钴，或氧化态为 II 和/或 III 的铁、 X 是配位基团或桥接基团、 Y 是平衡现有电荷 z 的相应化学计量的反离子，其中 z为金属络合物的电荷，可以是正电荷、零电荷或负电荷、 n 是 1 到 4 之间的整数、 p 是 0 至 15 之间的整数、 qz/ Y 的电荷 行式（2）、（3）或（4）的配体 且 A 和 R1 至 R8 具有说明中给出的含义。
• US5969171A
  申请人：——

  公开号：US5969171A

  公开（公告）日：1999-10-19
• Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics
  作者：Kui Cheng、Qing-Zhong Zheng、Yong Qian、Lei Shi、Jing Zhao、Hai-Liang Zhu

  DOI：10.1016/j.bmc.2009.10.037

  日期：2009.12

  A series of peptide and Schiff bases (PSB) were synthesized by reacting salicylic acid, primary diamines with salicylaldehyde or its derivatives, and 40 of which were newly reported. The inhibitory activities against Escherichia coli beta-ketoacyl-acyl carrier protein synthase III (ecKAS III) were investigated in vitro and molecular docking simulation also surveyed. Top 10 PSB compounds which posses both good inhibitory activity and well binding affinities were picked out, and their antibacterial activities against Gram-negative and Gram-positive bacterial strains were tested, expecting to exploit potent antibacterial agent with broad-spectrum antibiotics activity. The results demonstrate compound N-(3-(5-bromo-2-hydroxybenzylideneamino)propyl)-2-hydroxybenzamide (2d) can be as a potential antibiotics agent, displaying minimal inhibitory concentration values in the range of 0.39-3.13 mu g/mL against various bacteria. Crown Copyright (c) 2009 Published by Elsevier Ltd. All rights reserved.